Uremia enhances the blood pressure response to erythropoietin

Clinical and Experimental Hypertension

Volumn 19, Issue 4, 1997, Pages 389-401

  Lacasse M, S ^b   Kingma, I ^b   Lariviere R ^b   Grose, J H ^b   Lebel, M ^a  

^a LAVAL UNIVERSITY   (Canada)

^b NONE

Author keywords

erythropoietin; hypertension; remnant kidney model; renal failure

Indexed keywords

RECOMBINANT ERYTHROPOIETIN;

ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; CONTROLLED STUDY; HYPERTENSION; KIDNEY FAILURE; MALE; NEPHRECTOMY; NONHUMAN; RAT; SUBCUTANEOUS DRUG ADMINISTRATION; UREMIA;

EID: 0030992789     PISSN: 10641963     EISSN: None     Source Type: Journal    
DOI: 10.3109/10641969709084503     Document Type: Article

References (25)

1. Lebel, M., Kingma, I., Grose, J.H., Langlois, S. Effect of recombinant human erythropoietin therapy on ambulatory blood pressure in normotensive and in untreated borderline hypertensive hemodialysis patients. Am J Hypertens 1994, 9: 545-551.
2. Buckner, F.S., Eschbach, J. W., Haley, N.R., Davidson, R.C., Adamson, J.W., Hypertension following erythropoietin therapy in anemic hemodialysis patients. Am J Hypertension 1990; 3: 947-955.
3. Abraham, P.A., Macres, M.G. Blood pressure in hemodialysis patients during amelioration of anemia with erythropoietin. J Am Soc Nephrol 1991; 2: 927-936.
4. Canadian Erythropoietin Study Group. Effect of recombinant human erythropoietin therapy on blood pressure in hemodialysis patients. Am J Nephrol 1991; 11: 23-26.
5. Ludwig, H., Fritz, E., Kotzmann, H., Höcker, P., Gesslinger, M., Barnes, U., Erythropoietin treatment of anemia associated with multiple myeloma. N Engl J Med 1990; 322: 1693-1699.
6. Pincus, T., Olsen, N.J., Russell, J., Wolfe, F., Harris, E.R., Schnitzer, T.J., Boccagno, J.H., Krantz, S.B. Multicenter study of recombinant human erythropoietin in correction of anemia in rheumatoid arthritis. Am J Med 1990; 89: 161-168.
7. Fischl, M., Galpin, J.E., Levine, J.D., Groopman, J.E., Henry, D.H., Kennedy, P., Miles, S., Robbins, W., Starrett, B., Zalusky, R., Abels, R.I., Tsai,H.C., Rudnick, S.A. Recombinant human erythropoietin for patients with AIDS treated with zidovudine. N Engl J Med 1990; 322: 1488-1493.
8. Berglund, B., Ekblom, B. Effect of recombinant human erythropoietin treatment on blood pressure and some haematological parameters in healthy men. J Intern Med 1991; 229: 125-130.
9. Muntzel, M., Hannedouche, T., Lacour, B., Drücke, T. Effect of erythropoietin on hematocrit and blood pressure in normotensive and hypertensive rats. J Am Soc Nephrol 1992; 3: 182-187.
10. Gretz, N., Waldherr, R., Strauch, M. The remnant kidney model. In: Gretz N, Strauch M. Eds. Experimental and genetics rat models of chronic renal failure. Basel, Karger: 1993, 1-28.
11. Tan, C.C., Eckardt, K.-U., Ratcliffe, P.J. Organ distribution of erythropoietin messenger RNA in normal and uremic rats. Kidney Int 1991; 40: 69-76.
12. Flaharty, K.K., Caro, J., Erslev, A., Whalen, J.J., Morris, E.M., Bjornsson, T.D., Vlasses, P.E. Pharmakokinetics and erythropoietin response to human recombinant erythropoietin in healthy men. Clin Pharmacol Ther 1990; 47: 557-564.
13. Winearls, C.G., Oliver, D.O., Pippard, M.J., Reid, C., Downing, M.R., Cotes, P.M. Effect of human erythropoietin derived from recombinant DNA on the anaemia of patients maintained by chronic haemodialysis. Lancet 1986; 2: 1175-1178.
14. Eschbach, J. W., Egrie, J.C., Downing, M.R., Browne, J.K., Adamson, J.W. Correction of the anemia of end-stage renal disease with recombinant human erythropoietin: results of the Phase I and II clinical trial. N Engl J Med 1987; 316: 73-78.
15. Gretz, N., Lassare, J., Kraft, K., Waldherr, R., Meisinger, E., Strauch, M., Efficacy and side effects of erythropoietin used in the treatment of anemia of uremic rats. Contr Nephrol 1988; 60: 236-244.
16. Eggena, P., Willsey, P., Jamogotchain, N., Truckenbrod, L., Hu, M.S., Barrett, J.D., Eggena, M.P., Clegg, R., Nakhoul, F., Lee, D.B.N. Influence of recombinant human erythropoietin on blood pressure and tissue renin-angiotensin systems. Am J Physiol 1991; 261: E642-E646.
17. Muntzel, M., Hannedouche, T., Lacour, B., Drücke, T.B. Erythropoietin increases blood pressure in normotensive and hypertensive rats. Nephron 1993; 65: 601-604.
18. Vaziri, N.D., Zhou, X.J., Smith, J., Oveisi, F., Baldwin, K., Purdy, R.E. In vivo and in vitro pressor effects of erythropoietin in rats. Am J Physiol 1995; 269: F838-F845.
19. Anastossiades, E., Howarth, D., Howarth, J., Shanks, D., Waters, H., Hyde, K., Yin, J.L., Geary, C., Gokal, R. : Influence of blood volume on the blood pressure of predialysis and peritoneal dialysis patients treated with erythropoietin. Nephrol Dial Transplant 1993; 8: 621-625.
20. Hori, K., Onoyama, K., Iseki, K., Fujimi, S., Fujishima, M. Hemodynamic and volume changes by recombinant human erythropoietin in the treatment of anemic hemodialysis patients. Clin Nephrol 1990; 33: 293-298.
21. Lebel, M., Grose, J.H., Kingma, I., Langlois, S. Plasma endothelin of subcutaneous erythropoietin replacement therapy. Clin Exper Hypertens (A) 1994; 16: 565-575.
22. Vallance, P., Leone, A., Calver, A., Collier, J., Moncada, S. Accumulation of an endogenous inhibitor of nitric oxide synthesis in chronic renal failure. Lancet 1992; 339: 572-575.
23. Anagnostou, A., Liu, Z., Steiner, M., Chin, K., Lee, E.S., Kessimian, N., Noguchi, C.T. Erythropoietin receptor mRNA expression in human endothelial cells. Proc Natl Acad Sci USA 1994; 91: 3974-3978.
24. Carlini, P.G., Dusso, A.S., Obialo, C.I., Alvarez, U.M., Rothstein, M. Recombinant human erythropoietin increases endothelin-1 release by endothelial cells. Kidney Int 1993; 43: 1010-1014.
25. Heidenreich, S., Rahn, K.-H., Zidek, W. Direct vasopressor effect of recombinant human erythropoietin on renal resistance vessels. Kidney Int 1991; 39: 259-265.